Emerging evidence suggests the involvement of brain ACE2 expression in the pathogenesis of COVID-19; therefore, it is of a great interest to explore the neurological effects of SARS-CoV-2 and the associated clinical manifestations in patients with COVID-19 [9]. The gene discussed is ACE2; the disease is COVID-19.